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Abstract
Objective: The objective of the study was to determine if con-
sumption of conjugated linoleic acid (CLA) by mice could 
induce apoptosis in adipose tissue. Other objectives were 
to determine the influence of feeding mice CLA for ≤2 
weeks on body fat, energy expenditure, and feed intake.
Research Methods and Procedures: A mixture of CLA isomers 
(predominantly c9,t11 and t10,c12) was included in the 
AIN-93G diet at 0, 1, and 2%, and fed to mice for 12 days 
(Trial 1), or was included at 2% and fed to mice for 0, 5, 
and 14 days (Trial 2). Feed intake was measured daily and 
energy expenditure was determined by direct calorimetry 
on day 9 in Trial 1. Retroperitoneal fat pads were analyzed 
for apoptosis by determination of DNA fragmentation.
Results: Dietary CLA reduced feed intake by 10% to 12% (p < 
0.01), but either did not influence or did not increase en-
ergy expenditure as indicated by heat loss. Body weight 
was not influenced by consumption of CLA in Trial 1 but 
was increased (p < 0.01) by CLA in Trial 2. Weights of ret-
roperitoneal, epididymal, and brown adipose tissues were 
lower (p < 0.01) in animals fed CLA, although liver weight 
was increased (p < 0.10; Trial 1) or not changed (Trial 2). 
Analysis of retroperitoneal fat pad DNA from both trials 
indicated that apoptosis was increased (p < 0.01) by CLA 
consumption.
Discussion: These results are interpreted to indicate that CLA 
consumption causes apoptosis in white adipose tissue. 
This effect occurs within 5 days of consuming a diet that 
contains CLA.
Keywords: mouse, food intake, conjugated linoleic acid, apop-
tosis, body fat
Introduction
Several prominent health benefits have been attributed 
to consumption of conjugated linoleic acid (CLA). In ro-
dents, dietary CLA stops cancer growth (1), improves 
glucose tolerance (2), reduces body fat, and increases ox-
ygen consumption (3) (4) (5). The mechanism by which 
CLA mediates any of these benefits is yet to be deter-
mined. However, Ip et al. (1) observed that an inhibitory 
effect of CLA on mammary epithelial cell growth was 
associated with apoptosis. This clue, coupled with the 
observation that centrally administered leptin can cause 
apoptosis of adipocytes (6), led us to test the hypothe-
sis that dietary CLA causes apoptosis of adipocytes. We 
also determined effects of dietary CLA in lines of mice 
that differed genetically with regard to obesity.
Research Methods and Procedures
Materials
Male MH (12 weeks of age; n = 30), ML (12 weeks of age; 
n = 30), C57BL/6J (10 weeks of age; n = 30) and M16 (re-
tired breeders 26 to 30 weeks of age; n = 20) were ob-
tained from our colony. The MH and ML mice were 
generated by selection for high and low heat loss, re-
spectively (7) (8). The MH mice emit 60% more heat than 
ML mice, are leaner, and consume more feed. However, 
MH and ML mice are not different in body weight at 
any age up to at least 16 weeks. The M16 mice were gen-
erated by selection for maximum body weight gain dur-
ing 3 to 6 weeks of age (9). These mice exhibit obesity 
relative to unselected controls (10). The C57BL/6J mice 
from our colony are from the Jackson Laboratories col-
ony (Bar Harbor, ME). The C57BL/6J mice are similar 
to ML mice with regard to low heat loss and feed intake 
but similar to MH mice with regard to low body fat-
ness. The growth rate of this inbred strain is slower than 
that of the other strains used in this study (11). Animal 
procedures were conducted as approved by the Uni-
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versity of Nebraska Institutional Animal Care and Use 
Committee.
CLA (95% conjugated diene) was purchased from 
Nu-Chek-Prep (Elysian, MN) and mixed into a purified 
base diet (AIN-93G) by Dyets, Inc. (Bethlehem, PA). Soy 
oil was replaced with CLA (1:1, w/w) to create the fol-
lowing diets: 1) 0% CLA, 7% soy oil; 2) 1% CLA, 6% soy 
oil; and 3) 2% CLA, 5% soy oil. The CLA is reported by 
the manufacturer to be 44% t10,c12; 10% c10,c12; 41% 
c9,t11/t9,c11; and 5% other isomers.
Protocol
The experiment was composed of two trials. In Trial 1, 
MH, ML, and C57BL/6J mice were housed individually 
at 22 °C, under a photoperiod of 12 hours light and 12 
hours dark (lights out at 7:00 PM), and fed AIN-93G diet 
for 1 week before data collection. Mice were randomly 
assigned to one of the three experimental diets that were 
fed for 12 days. There were 10 replications of the nine 
diet-by-line combinations. Experimental diets were fed 
to the nine mice of the first replicate on day 1 of the 
study. On day 2, the second replicate started to consume 
the experimental diet and so forth, so that by day 10 all 
90 animals were consuming the experimental diet.
Direct calorimetry was used to measure heat loss 
during a 4-hour period beginning at 5:00 PM on day 9 
for each replicate. A detailed description of our calorim-
etry method has been published elsewhere (7). Briefly, 
the mice were placed individually into direct calorime-
ters (Thermonetics Corp., San Diego, CA), which mea-
sure voltage change that results from movement of heat 
energy through the walls of the calorimeters. On the day 
of calorimetry, feed was unavailable from 12:00 AM un-
til 7:00 PM. Thus, heat loss was determined in the fasted 
and in the refed state for each animal. Heat loss was de-
termined at 1-minute intervals for 2 hours in each state. 
Water was not available in the calorimeter chambers.
Three days after calorimetry, between 8:00 AM and 
10:00 AM, mice were killed by CO2 asphyxia. Livers, 
brown epididymal, and retroperitoneal fat pads were re-
moved and weighed. The liver and brown fat pad from 
each mouse were further analyzed for lipid content by 
extraction with chloroform:methanol (2:1, v/v) and 
0.05% sulfuric acid (12). Retroperitoneal fat pads from 
animals fed 2% CLA (n = 12) and from animals fed the 
control diet (n = 9) were frozen in liquid nitrogen and 
stored (-80 °C) until being analyzed for apoptosis.
In Trial 2, 20 M16 mice were randomly allocated to 
three treatments and fed either 0% CLA for 14 days (n = 
7), 0% CLA for 9 days and then 2% CLA for 5 days (n = 
6), or 2% CLA for 14 days (n = 7). Body weight change 
was recorded and tissues were weighed and assayed for 
apoptosis as in Trial 1.
Apoptosis Assays
Apoptosis assay was based on internucleosomal DNA 
degradation (6). Retroperitoneal fat pads were homog-
enized in digestion buffer (100 mM NaCl, 10 mM tris(
hydroxymethyl)aminomethane-HCl [pH 8.0], 25 mM 
EDTA, 0.5% sodium dodecyl sulfate, and 0.2 mg/ml 
Figure 1. Heat loss, Trial 1. In the fasted state, genetic line (p < 0.01) and genetic line by CLA interaction (p < 0.02) are significant, 
but CLA is not (p > 0.5). In the refed state, line is significant (p < 0.01); CLA (p = 0.13) and line by CLA interaction (p > 0.5) are not 
significant. SEM was 22 and 18 for fasted and refed states, respectively.
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proteinase K), nuclei and cellular debris were removed 
by centrifugation, and the supernatant was incubated 
at 55 °C overnight. The supernatant was then extracted 
once with phenol:chloroform:isoamyl alcohol (25:24:1) 
and twice with chloroform/isoamyl alcohol and then 
precipitated in ethanol. The DNA was resuspended in 
tris(hydroxymethyl)aminomethane-EDTA buffer and 
treated with 0.1 U of deoxyribonuclease-free ribonucle-
ase. One microgram of normalized DNA was labeled 
with [32P]deoxycytidine triphosphate using the Klenow 
fragment of DNA polymerase I, extracted, separated 
by agarose gel electrophoresis, and viewed by autora-
diography for the laddering pattern that is character-
istic of apoptosis. The intensity of signals for the frag-
ment of high molecular weight and fragments of low 
molecular weight in each sample were quantified by 
image analysis. The percentage of the intensity for low 
molecular weight fragments versus the high molecular 
weight fragment was expressed as the degree of DNA 
fragmentation.
Data Analyses
Heat loss (kilocalories per day) and feed intake (grams 
per day) were analyzed based on animal, body weight 
(kg), and exponent of body weight (kg75). The General 
Linear Models procedure of Statistical Analysis Sys-
tem (13) was used to compute ANOVA. For heat loss, 
the model included effects of CLA level, genetic line, ge-
netic line by CLA interaction, and animal within CLA 
level-genetic line class. Heat loss was analyzed sepa-
rately for the fed state and for the fasted state. Feed in-
take and body weight analyses included the mentioned 
effects plus the effect of day. Mean squares for animal 
within CLA level-genetic line class were used as denom-
inator of the F test for CLA level, genetic line, and CLA 
level by genetic line interaction effects. Tissue weights 
and apoptosis were analyzed similarly except that the 
model did not include animal, and the residual mean 
squares were used to determine significance. Apopto-
sis data were transformed by raising to the one-third 
power to meet the ANOVA assumption of homoge-
neous variance.
Table 1. Heat loss in fasted and refed mice as influenced by genetic line and dietary CLA expressed on a 24-hour basis either per 
animal, per body weight (kg), or per exponent of body weight (kg75) in Trial 1.
                                                                  Fasted                                                                                         Refed
Main effect                   Heat                   Heat/BW              Heat/BW75                Heat      Heat/BW      Heat/BW75
Line
C57  7.0  266  107  9.6  366  147
ML  10.4  279  123  13.4  360  158
MH  14.4  400  174  16.5  456  199
SEM  0.43   12.3  5.2   0.39  10.3   4.4 
 (p < 0.01)* (p < 0.01)  (p < 0.01) (p < 0.01)  (p < 0.01)  (p < 0.01) 
CLA
0%  11.0  317  137  12.9  378  162
1%  10.7  320  136  13.7  408  174
2%  10.0  308  131  12.9  396  168
SEM  0.43   12.3  5.2  0.39  10.3   4.4  
 (p > 0.2)     (p > 0.5)      (p > 0.5)    (p > 0.2)  (p = 0.13)  (p = 0.18) 
      
BW, body weight.
* Significance of main effect.
Table 2. Feed intake (grams per day) expressed either per an-
imal, per body weight (kg), or per exponent of body weight 
(kg75) in Trial 1.
Main effect  Feed intake  Feed/BW  Feed/BW75
Line
 C57  4.2  159  64
 ML  4.5  121  53
 MH  5.5  153  66
 SEM  0.11  3.7  1.5
  (p < 0.01)*  (p < 0.01)  (p < 0.01)
CLA
 0%  5.0  153  65
 1%  4.7  144  61
 2%  4.4  137  58
 SEM  0.11  3.7  1.5
  (p < 0.01)  (p < 0.01)  (p < 0.01)
BW: body weight.
* Significance of main effect.
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Results and Discussion
Heat Loss and Feed Intake (Trial 1)
We expected that feeding mice CLA would stimulate 
heat production because West et al. (4) had reported that 
it increases oxygen consumption. Their mice consumed 
feed ad libitum, so we used a similar protocol. Our heat 
loss results are presented in Figure 1 and Table 1. Feed 
intake results are presented in Table 2. Results in Tables 
1 and 2 are presented based on animal, body weight, and 
an exponential function of body weight commonly con-
sidered to be “metabolic body weight” (weight75), be-
cause there is some controversy as to which is appropri-
ate, especially when comparing energy expenditure with 
feed consumption (14). In fasted mice, regardless of de-
nominator used for expressing the results, the genetic 
line by CLA interaction indicated that CLA suppresses 
heat loss in MH mice but stimulates heat loss in ML and 
C57BL/6J mice (Figure 1; p < 0.05). The magnitude of 
this interaction is small and its biological significance is 
unclear. No such interaction was observed in refed mice. 
CLA tended to increase heat production in refed mice (p 
= 0.13), but only when expressed per body weight (Ta-
ble 1). This effect (8% increase) is similar to the 12% in-
crease in energy expenditure attributed to CLA by West 
et al. (4). Perhaps the response we observed was less ro-
bust due to the shorter period of CLA consumption in 
our experiment (9 days vs. 6 weeks). Altogether, the heat 
loss results indicate that CLA caused either no change or 
an increase in energy expenditure, while reducing feed 
consumption. Feed intake was reduced 10.5% to 12% by 
CLA (p < 0.01; Table 2) in all three lines. This is similar to 
the 9.6% reported by West et al. (4). There was no inter-
action of genetic line and diet.
Body Weight (Trials 1 and 2)
Consumption of CLA, despite reducing feed intake, did 
not cause a loss of body weight. During Trial 1, change 
in body weight between day 1 and day 12 was 2.4, 1.5, 
and 1.2 g for mice fed 0, 1%, and 2% CLA, respectively 
(SEM = 0.63; p > 0.37). There was no genetic line-by-
diet interaction effect on body weight. C57BL/6J mice 
weighed less than MH or ML mice. This was partly be-
cause they were 2 weeks younger, but even at constant 
age C57BL/6J mice weighed less than MH or ML mice 
(11). In Trial 2, consumption of CLA had a positive ef-
fect on body weight. At the end of the 14-day period, 
the body weight of mice fed CLA for 0, 5, and 14 days 
changed -7.1, 1.6, and -0.6 g, respectively (SEM = 2.0; p 
< 0.01).
Figure 3. Trial 2, weight of brown (BAT), epididymal (EPI), 
retroperitoneal (RP), and subcutaneous (SC) fat pads and of 
the liver (scaled to 10% of actual weight) and heart as influ-
enced by 2% CLA fed for either 0, 5, or 14 days. *CLA effect (p 
< 0.01). Error bars represent SEM.
Figure 2. Trial 1, weight of brown (BAT), epididymal (EPI), 
and retroperitoneal (RP) fat pads and of the liver (scaled to 
10% of actual weight) as influenced by line (top) and dietary 
CLA (bottom). Genetic line affected all tissues (p < 0.01). **CLA 
effect (p < 0.01). *CLA effect (p < 0.10). Genetic line by CLA in-
teraction was not significant for all tissues (p > 0.5). Error bars 
represent SEM.
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Tissue Weights (Trials 1 and 2)
In Trial 1, brown, epididymal, and retroperitoneal fat 
pad weights were each significantly reduced by di-
etary CLA (p < 0.01). Significant variation in each tis-
sue weight was also accounted for by genetic line (p < 
0.01), but there was no diet-by-genetic line interaction. 
Therefore, only the main effects of diet and of line are 
depicted in Figure 2. Consumption of CLA reduced the 
weight of epididymal, retroperitoneal, and brown fat 
pads. This could potentially be explained by an increase 
in adipose tissue hormone-sensitive lipase activity com-
bined with a reduction of lipoprotein lipase activity as 
observed by Park et al. (3). These changes in enzyme ac-
tivity would lead to a net loss of fatty acids from the tis-
sue. Indeed, the brown fat pads of CLA-fed mice in Trial 
1 contained less lipid. The lipid content of mice fed 0, 
1%, and 2% CLA was 52%, 42%, and 42%, respectively 
(SEM = 1.7; p < 0.01). If fatty acid oxidation was not con-
currently stimulated, the circulation of fatty acid to the 
liver and subsequent re-esterification could potentially 
cause an increase in liver weight. Our CLA-fed mice in 
Trial 1 tended to exhibit increased liver weight (7.6%; p < 
0.10). West et al. (4) observed that feeding mice 1% CLA 
for 6 weeks caused liver weight to increase by 22%. The 
lipid content of livers from mice fed 0, 1%, and 2% CLA 
was 10.7%, 11.4%, and 12.9%, respectively (SEM = 1.4%; 
p > 0.5). Therefore, any increase in liver weight that may 
have occurred in our mice due to CLA intake does not 
appear to have resulted from lipid accumulation. Nev-
ertheless, CLA intake dramatically reduced the weight 
of fat pads. The relatively small reduction in feed intake 
by CLA-fed mice during the 12 days probably does not 
account for the fat loss. Others have argued this point 
(3) (4), and in studies using mild feed restriction, we 
have not observed changes in fat pad weight (our un-
published observations). Normally fat depletion due to 
feed restriction is accompanied by a reduction in body 
weight in mature animals; we did not observe such a re-
duction in this study.
In Trial 2, brown, epididymal, retroperitoneal, and 
subcutaneous fat pads were all reduced in CLA-fed an-
imals (p < 0.01; Figure 3). The effect of CLA was appar-
ent after only 5 days of continuous consumption. The 
weight of fat pads after 5 days of CLA intake was not 
different (p > 0.10) from the weight of corresponding 
pads on day 14. In contrast, heart and liver weights were 
not affected by dietary CLA.
Apoptosis (Trials 1 and 2)
Apoptosis was increased in the retroperitoneal fat pads 
of mice fed 2% CLA compared with those consuming 
the control diet (Figure 4; p < 0.01). After either 5 or 14 
days of CLA consumption, the incidence of apoptosis 
was at least 4-fold greater than the incidence in control 
mice. This apoptosis cannot be accounted for by the 10% 
to 12% reduction in feed intake. Apoptosis was not ob-
served after restricting feed intake by 60% (6). CLA has 
been reported to cause apoptosis of mammary epithe-
lial cells (1), and it reduces cell number in preadipocyte 
cultures (15) (16). The latter effect has been attributed to 
inhibition of proliferation and is not due to cytoxicity, 
as indicated by low media lactate dehydrogenase activ-
ity and trypan blue exclusion. However, apoptosis was 
not specifically assayed (16). We do not know whether 
apoptosis can be detected by trypan blue exclusion but 
assume that it does not cause release of intracellular en-
zymes. Our observation that CLA induces apoptosis 
in adipose tissue is consistent with two recent reports. 
First, dietary CLA caused apoptosis in mouse adipose 
tissue (17). Second, addition of CLA caused apoptosis 
in cultured 3T3-L1 cells (18). We conclude that dietary 
CLA can cause apoptosis in mouse adipose tissue.
Figure 4. Apoptosis in retroperitoneal fat pads. Effect of CLA pooled across Trials 1 and 2 (p < 0.01). From left to right, bars repre-
sent data from 9, 12, 7, 6, and 7 animals. SE is 0.19.
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Given the incidence of obesity among humans, the 
fact that CLA selectively reduces body fat deposits (ver-
sus lean), and the incomplete understanding of how 
CLA mediates this effect, the observation that CLA pro-
motes apoptosis in adipose tissue warrants attention.
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